Life Sciences Investment Forum, Parc Científic de Barcelona 6th February 2020
Foro Capital Pymes, Canaan R&I, Keiretsu Forum and Parc Científic de Barcelona, will offer 10 selected companies the opportunity to present their investment proposals to the investment community.
Each company will have 8 minutes to present its investment proposal plus a round of questions.
Companies wishing to present their investment proposal to investors at the forum should download the executive summary form from www.forocapitalpymes.com and send it for evaluation by the Selection Committee to firstname.lastname@example.org.
Investors who will participate:
Investors who will attend the investment forum, upon invitation by the organization, national and international, all with experience and/or interest in investment in companies in this sector, and with an industrial profile, venture capital, family office, corporate banking … all with investment capacity above € 0.5M per project.
This is the second edition of the investment forum in the life sciences sector.
About the organizers:
Parc Científic de Barcelona: Parc Científic de Barcelona is one of Europe’s leading ecosystems for research, technology transfer and innovation in life sciences. Located in Barcelona, within the knowledge portal, the Parc has more than 100,000 m2 at the disposal of an active Community of almost 3,000 professionals.
Foro Capital Pymes: Foro Capital Pymes is an entity that organizes investment forums between Spanish SMEs and investors. The most important national and international investors (family office, venture capital, venture capital, venture capital, corporate, etc.) and also financing entities attend the forums.
Canaan R&I: CANAAN is a Venture Capital Club created for the implementation and management of investment processes in companies, patents and lines of research.
Keiretsu Forum: Keiretsu Forum is the largest international network of private investors. With 53 offices in 27 countries on four continents. The Keiretsu Forum Network of private investors has invested more than 200 million dollars in hundreds of companies.